Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Schemas

Schemas

A schema is a mental construct consisting of a cluster or collection of related concepts (Bartlett, 1932). There are many different types of schemata, and they all have one thing in common: schemata are a method of organizing information that allows the brain to work more efficiently. When a schema is activated, the brain makes immediate assumptions about the person or object being observed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vocal Health of Pastors in the Protestant Church in Germany.

Journal of voice : official journal of the Voice Foundation·2026

Same author

Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

Blood advances·2026

Same author

Adherence to Multi-Target Stool DNA Testing for Colorectal Cancer Screening Among Veterans and Civilians Enrolled in Veterans Health Administration Insurance Programs.

Military medicine·2026

Same author

Brentuximab Vedotin after AlloSCT for Relapsed/Refractory Hodgkin Lymphoma: GHSG BV-ALLO Phase II Trial.

Blood advances·2026

Same author

Accuracy of heart rate measurement using AirPods Pro 3 during graded treadmill exercise: A laboratory-based validation study.

PLOS digital health·2026

Same author

Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.

Alimentary pharmacology & therapeutics·2026

Same journal

Deutsche medizinische Wochenschrift (1946)·2026

Same journal

["Not everything that looks like a tumor..." - Pulmonary tularemia with hilar lymphadenopathy].

Deutsche medizinische Wochenschrift (1946)·2026

Same journal

[Emergency management of sickle cell disease].

Deutsche medizinische Wochenschrift (1946)·2026

Same journal

[Hereditary dehydrated stomatocytosis (= hereditary xerocytosis) - Interesting hummingbird or clinically relevant diagnosis?]

Deutsche medizinische Wochenschrift (1946)·2026

Same journal

[Diagnosis of Congenital Hemolytic Anemias in Adults].

Deutsche medizinische Wochenschrift (1946)·2026

Same journal

[46-year-old female patient with right upper abdominal pain].

Deutsche medizinische Wochenschrift (1946)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 12, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

[Hodgkin Lymphoma - Update 2018].

Michael Fuchs¹

¹Universitätsklinikum Köln (AöR), Klinik I für Innere Medizin, German Hodgkin Study Group (GHSG).

Deutsche Medizinische Wochenschrift (1946)

|April 4, 2018

Summary

This summary is machine-generated.

Hodgkin Lymphoma is a highly curable cancer. Current treatments include PET-adapted BEACOPPescalated therapy and maintenance with Brentuximab Vedotin for relapsed cases. New PD-1 inhibitors offer further treatment options.

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

Related Experiment Videos

Last Updated: Feb 12, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

Area of Science:

Oncology
Hematology
Clinical Therapeutics

Background:

Hodgkin Lymphoma is a curable malignancy in adults.
PET-adapted BEACOPPescalated is the standard first-line treatment for advanced disease.
A majority of patients achieve remission with four cycles of BEACOPPescalated.

Purpose of the Study:

To summarize current treatment standards for Hodgkin Lymphoma.
To highlight recent advancements in therapy, including maintenance and relapsed treatment options.
To discuss ongoing research exploring novel agents in earlier treatment lines.

Main Methods:

Review of current clinical guidelines and recent therapeutic approvals.
Analysis of standard first-line, maintenance, and relapsed treatment protocols.
Discussion of ongoing clinical trials investigating PD-1 inhibitors.

Main Results:

PET-adapted BEACOPPescalated therapy is effective for advanced Hodgkin Lymphoma.
Brentuximab Vedotin serves as a maintenance therapy post-autologous stem cell transplantation.
PD-1 inhibitors (Nivolumab, Pembrolizumab) are approved for relapsed disease post-Brentuximab Vedotin.

Conclusions:

Hodgkin Lymphoma treatment has evolved significantly with high cure rates.
Novel therapies like PD-1 inhibitors are being integrated into earlier treatment stages.
Future research aims to optimize treatment by reducing side effects and improving outcomes.